Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

783 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.
Koirala A, McRae J, Britton PN, Downes M, Prasad SA, Nicholson S, Winkler NE, O'Sullivan MVN, Gondalwala F, Castellano C, Carey E, Hendry A, Crawford N, Wadia U, Richmond P, Marshall HS, Clark JE, Francis JR, Carr J, Bartlett A, McMullan B, Skowno J, Hannah D, Davidson A, von Ungern-Sternberg BS, Lee-Archer P, Burgoyne LL, Waugh EB, Carlin JB, Naing Z, Kerly N, McMinn A, Hunter G, Heath C, D'Angelo N, Finucane C, Francis LA, Dougherty S, Rawlinson W, Karapanagiotidis T, Cain N, Brizuela R, Blyth CC, Wood N, Macartney K. Koirala A, et al. Among authors: heath c. PLoS One. 2024 Sep 18;19(9):e0300555. doi: 10.1371/journal.pone.0300555. eCollection 2024. PLoS One. 2024. PMID: 39292730 Free PMC article.
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.
Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, McDonald E, Nicholson S, Perrett KP, Pittet LF, Rudraraju R, Stevens NE, Subbarao K, Curtis N; BRACE trial. Messina NL, et al. EBioMedicine. 2024 May;103:105100. doi: 10.1016/j.ebiom.2024.105100. Epub 2024 Apr 24. EBioMedicine. 2024. PMID: 38663355 Free PMC article.
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial.
Pittet LF, Messina NL, McDonald E, Orsini F, Barry S, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo M, Gardiner K, Gwee A, Jardim B, Lacerda MVG, Lucas M, Lynn DJ, Manning L, Perrett KP, Post JJ, Prat-Aymerich C, Richmond PC, Rocha JL, Rodriguez-Baño J, Warris A, Wood NJ, Davidson A, Curtis N; BRACE Trial Consortium Group. Pittet LF, et al. EClinicalMedicine. 2024 May 13;72:102616. doi: 10.1016/j.eclinm.2024.102616. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38774675 Free PMC article.
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination.
Messina NL, Germano S, Chung AW, van de Sandt CE, Stevens NE, Allen LF, Bonnici R, Croda J, Counoupas C, Grubor-Bauk B, Haycroft ER, Kedzierska K, McDonald E, McElroy R, Netea MG, Novakovic B, Perrett KP, Pittet LF, Purcell RA, Subbarao K, Triccas JA, Lynn DJ, Curtis N; BRACE Trial Consortium Group. Messina NL, et al. Clin Transl Immunology. 2025 Jan 25;14(1):e70023. doi: 10.1002/cti2.70023. eCollection 2025. Clin Transl Immunology. 2025. PMID: 39872402 Free PMC article.
Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.
Slavin M, van Hal S, Sorrell TC, Lee A, Marriott DJ, Daveson K, Kennedy K, Hajkowicz K, Halliday C, Athan E, Bak N, Cheong E, Heath CH, Orla Morrissey C, Kidd S, Beresford R, Blyth C, Korman TM, Owen Robinson J, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group. Slavin M, et al. Among authors: heath ch. Clin Microbiol Infect. 2015 May;21(5):490.e1-10. doi: 10.1016/j.cmi.2014.12.021. Epub 2015 Jan 14. Clin Microbiol Infect. 2015. PMID: 25677259 Free article.
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC. Maertens JA, et al. Among authors: heath ch. Lancet Infect Dis. 2025 Jun 17:S1473-3099(25)00224-5. doi: 10.1016/S1473-3099(25)00224-5. Online ahead of print. Lancet Infect Dis. 2025. PMID: 40541222
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial.
Connor MJ, Shah TT, Sukumar J, Basak D, Fiorentino F, Heath C, Horan G, Johnson N, Khoo V, Khoubehi B, Klimowska-Nassar N, Mangar S, McGrath J, Nohpal de la Rosa C, Price D, Rai B, Sarwar N, Smith A, Staffurth JN, Tam H, Thippu Jayaprakash K, Winkler M, Dudderidge T, Ahmed HU; IP2-ATLANTA Trial Investigators. Connor MJ, et al. Among authors: heath c. Eur Urol Oncol. 2025 Jun 13:S2588-9311(25)00148-8. doi: 10.1016/j.euo.2025.05.010. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40517058 Free article.
783 results